ATHNdataset Registry

{ "ATHNdataset Registry for Blood Disorders", "The ATHNdataset Registry is an observational study collecting health information from people with blood disorders like Hemophilia, Thrombosis, Hemophilia A, Hemophilia B, and Sickle Cell Disease. This registry aims to gather a large amount of real-world data to help doctors, scientists, and policymakers understand and improve treatments for these conditions. If you agree to participate, your health information from your Hemophilia Treatment Center (HTC) will be securely added to the registry and updated regularly. This includes details about your diagnosis, family history, test results, medications, and how your condition affects your daily life. The study plans to enroll 200,000 participants and will analyze this comprehensive data over 15 years to support research, advocacy, and public health reporting for the blood disorders community. Anyone evaluated for or potentially having a blood disorder who has an encounter with an ATHN Affiliate can join, regardless of age, as long as they or a legal representative can provide consent.", "design": "This is an observational study, meaning it collects health information without testing new treatments. It aims to enroll 200,000 participants.", "commitments": "If you participate, your health information will be included in the ATHNdataset Registry and updated regularly to reflect your current health status.", "compensation": "Not stated in the trial record.", "follow_up": "The study will analyze comprehensive clinical data over 15 years.", }

Study design
Not specified.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06820515

ATHNdataset Registry

Recruiting
Not specifiedAll AgesObservational
American Thrombosis and Hemostasis Network
~200,000 participants
Updated 2026-04-21 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Comprehensive real-world clinical data registry analysis, research, advocacy, and public health reporting for the blood disorders community
Measured over 15 years
Hemophilia
Thrombosis
Hemophilia A
Hemophilia B
Sickle Cell Disease
Glanzmann Thrombasthenia
Bleeding Disorder
Blood Disorder
Von Willebrand Diseases
1 sites across 1 states
North Carolina1
  • Tammuella Chrisentery-Singleton, M.D. · PRINCIPAL_INVESTIGATOR · American Thrombosis and Hemostasis Network

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Any participant evaluated for or the potential to have a blood disorder who has an encounter with an ATHN Affiliate.
Participants of any age.
Participant is able to provide consent or assent; a Legally Authorized Representative (LAR) may provide consent on a participant's behalf if a participant is unable to provide self-consent

Exclusion

Any participant unable to provide consent or assent to participate in the ATHNdataset
  • Comprehensive real-world clinical data registry analysis, research, advocacy, and public health reporting for the blood disorders community15 years

    The ATHNdataset Registry objective is to develop a secure, comprehensive registry of real-world clinical data to support standardized comprehensive health information for persons living with blood disorders and public health reporting for the blood disorders community